Treatment of Multiple Sclerosis

©Copyright 1998 by Hans A. Nieper, M.D. Germany
(Explore Issue: Volume 8, Number 6)

All over the world, the conflict between the orthodox establishment on the one hand and reform suggestions on the other hand is taking its course. This refers to physics, to the physical world-vision, to sociology, environmental consciousness and medicine as well. The conflict in medicine is particularly strong, especially in the consciousness of a majority of the population. In the United States, the orthodox establishment that is becoming more and more obsolete is also called "orthodox medicine" in colloquial speech. In Germany, the unfortunate term "Schulmedizin" (textbook medicine) has been applied, which is rather misleading. In reality, evolutionary positions in medicine are called "Schulmedizin," the positions generally termed as Schulmedizin are in reality orthodox and in vast areas already considered outside medicine.

It has to be pointed out, however, that only limited areas are at disposal in the area of medicine, and they are the object of much controversy. Particularly, therapy of internal diseases, nervous diseases and related indications are effected, more than the diagnosis of disease and disease complexes; surgery with its many branches that are always considered a "royal craft," untouched by all highly intellectual discussions, was not effected at all.

The conflict of opinions in the area of the treatment of internal diseases which in fact started more than twenty years ago with the Issels-proceedings has had a consequence that any clear-minded observer cannot help but recognize: Orthodox, formerly textbook medicine, has moved outside of applied techniques in reference to treatment of cancer, the treatment and prevention of cardiac arrest and also the treatment of arteriosclerosis. More than the defenders of this method would like to admit! The Issels-proceedings (cancer therapy) and the Kern tribunal (prevention of heart attack) have become history on the one hand, but have also led to developments that erode orthodox positions in the treatment of these diseases progressively and effectively.

The percentage of people suffering from multiple sclerosis is not as high as the lot that is threatened by cancer, heart or circulo-vascular disease. The frequency rate in central and north European countries is usually between 240 and 360 cases per 1 million residents. However, this form of disease has aroused great interest due to the typical long-term disorders that it causes, due to the typical symptoms and the problems that the afflicted and their loved ones have to battle with. There is a multiple sclerosis society in the United States that is publicly very active and is collecting vast amounts of money, with emphasis on "collecting." There is the DMSG (Deutsche Multiple-Sklerose Gesellschaft) in the Federal Republic of Germany, which is based in Munich and has several state branches. This society has managed very well to assure itself a medical and supposedly scientific hegemony and also, to establish a relatively good social position. Dr. Veronica Carstens [she is the wife of the present representative of the Federal Republic] was awarded the sponsorship, but that did not keep them from discrediting Dr. Carstens due to the well-known medical theories she supports. The wives of minister presidents Späth and Albrecht were also secured as sponsors on a state level.

Isn't it obvious that the downfall of established parties -- in spite of all honest efforts -- is directly related to the fact that reputed and dignified representatives of these parties are compliant in good will to these orthodox circles? Hasn't it ever occurred to anybody that this is finally leading to a vacuum that may be filled by the Green Party? Cancer therapy? Heart therapy? MS therapy? Nuclear energy? Canals in picturesque valleys? Environmental damage? Physical world-view, ether: yes or no? Gravity field energy? Tesla-weapons? Plasma ignition in place of catalysts? Wherever you go, politics have failed because the responsible politicians do not make an effort to get a second opinion on the grapevine of information they receive from the circles of orthodox scientists.

The style of activity of the DMSG that is clearly evident from the newsletters they publish has obviously led to extreme scandals for the past years, which we again and again hear from our patients. Meanwhile, another society has formed in the Federal Republic of Germany, the MSK (Selbsthilfegruppen für Multiple-Sklerose-Kranke e.V.). The imposing number of files that are kept by the MSK can only let you guess the extraordinary degree of criticism against the DMSG.

My personal medical activities were originally not geared toward the treatment of multiple sclerosis. My main interest was always in cancer, in the metabolic aspects of coronary and vascular disease and in bone metabolism. I owe it to a special development from my earlier scientific activities that I -- even though I treat internal and not nervous disorders -- possess the largest MS praxis that includes more than 1,300 clinical and ambulatory patients "just on the side." In addition, I do not even possess a comparable competition on an international basis. The treatment of MS in clinic and praxis has been going on for more than 20 years. Presently, more than 80% of our MS patients come from the United States, the rest is distributed over northern and central Europe, partially over Italy, South Africa, even East Africa, Australia including Tasmania and New Zealand. The clinical results we achieved are fundamentally better than any other therapy that has ever been applied. The unbelievable influx of MS patients, particularly from North America, has to be explained by "word of mouth." Maybe this is the reason that, back in the summer of 1984, the DMSG had publicly attacked me in the worst way and spread bad rumors about me. It can be easily predicted what this could lead to, particularly in regards to the patients.

 

The knowledge of the symptoms of multiple sclerosis has been extended in the last two years by American research in some significant points. Thus, I will take the liberty to present the causes and basis of this disease to the untrained audience.

The nerve fiber that leads from the nerve cell giving the impulse to subordinated control or success cells consists of a fiber that is also called central axon. This fiber is surrounded by a multiple layer of leafs, anywhere between five to over thirty layers. This
looks like as if there was a large leaf wrapped around a central fiber in multiple layers. The multiple layers of this leaf are called myelin. This giant "tobacco leaf" that is wrapped around the axis cylinder originates from a very special cell, the so-called oligodendroglia.

The various layers of the layered leafs that the myelin forms are basically identical to the structure of cell membranes in general. That means: they are double contoured, equipped with the ability to connect counterpole charges and thus fulfill the function of an electrical capacitor.

Prior to the end of 1983, the general opinion existed that myelin basically fulfills the function of an insulation layer around the central fiber. A publication that appeared in August 1984 in the magazine Science comes to a new conclusion: even though myelin may have the characteristics of an insulation, it was found that the capacitor system that has a relatively large surface formed by the myelin layers possesses an electrical shunt to the central axis fiber. The capacitor function of the myelin layers is thus made useful for the electrical properties of the central nerve fiber. In other words: we are dealing with the textbook Tesla-technique. It is highly possible that this system converts gravity field energy into electrical energy which is important for the function of the central nerve fiber. We are thus dealing here with the same technique that is now appearing on the market in Germany as plasma ignition. This technique allows a magnification of the igniting energy by 100 to 250 times. If you consider the significant number of layers in the myelin, then this magnification effect may be even greater in the case of human nerve fiber.

For a correct connection of electrical charges to the cell membrane, certain chemical components are needed in this membrane. This includes the so-called colamine phosphate (2-amino ethanol phosphate). This component in the cell membrane was first described in the Fifties by the famous American biochemist Chargaff. Substantial merits in the research of colamine phosphates which we will subsequently call EAP go on the account of the Italoamerican husband/wife research team Ferrari.

An insufficient supply of EAP in the cell membrane caused by nature would lead to the effect that the connection of electrical charges and thus also the capacitor function would become low standard. In fact it was determined that patients that tend to autoimmune disease apparently do not form enough EAP and do not discharge enough EAP in blood as well as in urine. This is also valid for patients that develop multiple sclerosis, but also other autoimmune diseases, i.e. in the lungs, the kidneys and other organs.

It was also discovered that the entire stock of cell membranes (not just the myelin layers) was found out of order in patients that have multiple sclerosis. This means that the porosity is abnormal at the membranes of the red blood cells. The electrostatic charges at the cells of the discharging urinary tracts are below value. There is a constant danger of rising urinary tract infections, because the electro-static defense filter that is usually responsible for the cleansing of the urinary tracts does not function sufficiently. Substantial merit for these discoveries goes to the American biochemist Galland.

Apart from that, the loss of charge capacity can be measured in any praxis, i.e. by using a RC measuring device.

When the connection of electrical charges on both layers of the cell membrane becomes insufficient, the capacitor potential decreases (normally, it can amount up to 70 mV). At the same time, the Tesla function becomes weaker, that means: the supply of stimulating or effector energy of the central nerve fibers has substantially decreased. Frequently, MS patients correctly described this symptom by intuition. The Tesla function or "Orgon box" function decreases in all the cells of the organism. The patients thus feel constantly cold; their body feels cold to others too. At the same time, the electrostatic barrier against occurring urinary tract infections fails. Numerous other phenomena could be observed, i.e. fragility of small capillaries, frequently occurring bruises, joint problems, etc. If such patients receive EAP medication, they feel less cold, the fragility of the capillaries is alleviated, they have less bruises.

Much accounts for the fact that this incapacity to form enough EAP for the membranes and to connect charges could be of hereditary origin. Especially in the case of American patients, next of kin also suffers from the disease. Identical twins have a rather identical degree of MS.

The electrical discharge of the membrane system has other consequences: It appears that the membranes are not sufficiently equipped any more against the aggression of immune bodies. These membrane and cell systems are easier victimized by the so-called autoimmune disease as it has been described, not only in cases of MS, but also in cases of other immune diseases. This condition can be compared to an empty battery that is going to break down fairly quickly , when not constantly charged.

In our further discussion of the causes of MS, we have to discuss the problem of cell membrane disorders and immune aggression.

 

The combination of functional membrane devaluation, possibly caused by lack of EAP, and subsequent damages by immune aggression caused by antibodies and lymph cells leads to a more or less complete decrease of myelin, to a "demyelinized disease."

Multiple sclerosis may include an inflammation process in the so-called blood liquid barrier, a segment in the small brain vessels that is responsible for the liquid and pressure exchange between blood and brain liquids. If this inflammation of the blood-liquid barrier is predominant, an MS-type disorder will occur that is untypical: combination with migraine headaches, after an attack a better regression to the original function, the opticus nerve in the back of the eye reveals less degenerative damage.

The German neurologist Kuwert who is serving at the Max Planck Society was one of the first to point out two different occurrences of MS. Occasionally, we are talking about type Kuwert I (a textbook-case of MS) and Kuwert II (blood-liquid barrier symptoms).

Actually, the merit for this distinction was earned by the renowned Swedish pathologist Broman (Göteborg). The private lecture that Professor Broman gave me in 1968 during a long drive about the pathological syndrome of MS has greatly added to my medical understanding.

MS is frequently diagnosed by a lumbar puncture to examine the brain liquid for inflammatory mutations. As little brain liquid
as possible should be taken, and this procedure should not be repeated after the diagnosis has been secured. The pressure stress thus effected on the already imbalanced blood-liquid barrier could lead to continuous headaches and even to an activation of the disease. The same is valid for an X-ray image of the spinal marrow or the brain. Repeated liquid samples and so-called invasive diagnostic measures should be avoided. But this important discovery is constantly overlooked.

We do not quite understand yet what leads to a probable EAP insufficiency in the cell membrane and to a decrease of membrane polarization. The opposite has been discovered as well: extreme membrane polarization by way of very strong connection of electrical charges, usually in the form of calcium. This may lead to a so-called malignant hyperthermia due to the increased Tesla- or Orgon-activity, even to combustion processes in the living person that is called spontaneous combustion. The opposite is the case in MS: the Tesla- or Orgon-activity is usually too low. There are other indications in which the EAP formation in the cell membrane has apparently decreased. This includes 'leukodystrophy" that can occur in small children. Therapeutic treatment with EAP salts takes care of the problem very well, because an artificial maturing of myelin is thus achieved.

Hereditary or family factors seem to be playing a role in the decreased ability to form membrane EAP. But there are other components. The effect of aluminum that can enter into the membrane is very suspicious. It seems to produce membrane damage in the nervous systems. We know this about "amyotrophic lateral sclerosis," because related discoveries have been made on Guam. Our ALS patients were subjected to a large degree of aluminum exposure. ALS can also be improved with EAP treatment; we have treated approximately 60 patients with it so far.

In the case of MS, the aluminum theory is not out of this world; the extreme consumption of beverages contained in aluminum cans in the USA arouses suspicion. Exposure to aluminum hydroxide, particularly from deodorants, seems to have an impact on Alzheimer's disease.

Another damage factor that has an effect on electrostatic membrane charges is the effectiveness of geopathic zones. They appear to be frequencies that are primarily transferred with the tachyon field. The primary noxa has neither electrical nor magnetic characteristics. 93% of all cancer patients are correlated with the exposure to geopathogenic effects; in the case of MS, there are between 75 and 80%. In the meantime, the scientific magazine Science has reported about this phenomenon. There is an increased risk of cancer if there are high voltage transmission lines nearby or if the affiicted persons have worked in transformer stations. This phenomenon is now subject to investigations by the American Environmental Protection Agency (EPA).

Dr. Carstens has particularly engaged herself in the investigation of damaging effects of geopathogenic zones onto man. I have had a very positive correspondence with her about this problematic area. However, the responsible parties of the DMSG are still voicing derogatory remarks about these discoveries and thus about the interests of their own sponsor.

In late 1984, I accepted an MS patient from Northern California, from the area of Eureka. Her husband reported that they both live in a zone of continuous earthquake activity, not very far from areas in which a person has to stand slanted on the ground instead of perpendicular, so that he does not fall (see my book Conversion of Gravity Field Energy). In this area, the frequency of MS amounts to more than 4,000 cases per 1 million residents (in the average), which is 10 times higher than the average nationwide.

Undoubtedly, MS patients (that includes everybody in general) should avoid the use of electric heating pads/blankets.

The other component that invokes the syndrome of MS rests in the formation of an immune aggression towards myelin. This auto-immune process is apparently started by a viral infection. The immunological defense process thus started is supposed to take a healing effect which seems to become autonomous later on and seems to attack, after a more or less longer latent period, the structures of the myelin membranes, occasionally even the blood-liquid barrier and possibly even intracellular membranes in the oligodendroglia instead of the actual virus.

The most important starter virus seems to be measles. Twenty years ago, Dr. Mannweiler at the Institute of Neurology Pette, Hamburg, apparently made this discovery. An equally important starter virus is obviously distemper, as we have known for approximately 15 years. Mumps virus, certain viruses of sheep and possibly very small viral components are subject to discussion.

We know now that the body possesses substances that deactivate or eliminate such undesirable malfunctions and immunological deviations. Particularly from the area of cancer research we have made discoveries that give an inside view into the function of such repairing substances. In reference to MS, the Belgian scientist Fisser has given a paper about this at the Royal Society in London. The repairing substances belong to the area of adrenaline cortex substances, or steroids. Certain steroid predecessors also play a role. We know about the repairing substances that are only effective if they possess a certain high level of electrical stimulation. If this is not the case, they may become ineffective despite their being immaculate. They could be looked at like a car without gas. The necessary stimulating energy is apparently drawn from the conversion of tachyon energy; they are dependent on the Tesla- or Orgon-activity of the cell membrane. These areas are, as mentioned above, below value particularly in MS patients. In addition, the monitoring systems may also be damaged by the already mentioned geopathogenic effect. They should not be sensitive towards substances whose damaging and inactivating effect onto steroids has been established: fluoride, platinum, nickel, aluminum?, chlorine?, mercury, silver (amalgam fillings!), chromium and possibly several other heavy metals. Basically all these toxic substances do damage the cell membrane electrofunctionally.

In any case, the frequency of MS is particularly great in industrial areas where chromium, nickel and other heavy metals are used (i.e. Ohio). In addition, usually drinking water is fluoridated heavily, which gravely damages the monitoring function of our organism, see autoimmune diseases and cancer.

Multiple sclerosis is particularly frequent in the northern regions of the world and in a certain way has its mirror image in the southern regions. You could argue that a more frequent exposure to sunlight could explain this phenomenon, since light could
activate monitoring systems against cancer and other immune diseases. An example is colon cancer: it decreases with increased exposure to sunlight. My own observations have shown that this argument is not convincing in the case of MS. Multiple sclerosis has its greatest frequency in areas of the milk industry. The case of the milk state Wisconsin with its high MS rate is typical; MS is 10 times higher in Texas than on the other side of the Rio Grande, in Mexico. Texans prefer Anglo-American milk foods, Mexicans consumé Iberian foods that are low in milk.

In South Africa we find a particular spread of MS in the province Natal near Durban, even though they have excellent sunlight. However, this area is famous for its milk industry. In Australia, similar to the case of Texas and Mexico, MS frequency is determined by the provincial borders. Market penetration with milk products is a provincial characteristic.

There are two significant theories that deal with the interaction of milk industry and MS frequency. One theory proposes that there are viral particles in the milk that cause the disease as a starter virus. The tendency to manifested MS is apparently already established in early youth, which supports this theory. In other words: if somebody in Arizona is struck with MS, the person was usually born in Ohio or Wisconsin. Another theory is from an English source and almost twenty years old: so-called glutenous, immune-active glucose-protein complexes from milk, possibly from grain, could activate the disease and cause it to be clinically manifested. If the patients would not have taken in the glutens, the disease would most likely never have manifested. The British Medical Journal published that only 63% of all cases that revealed an early tendency towards MS after careful examination were affiicted with the disease within eight to ten years. It is a fact that the established and progressing MS disease is only the tip of an iceberg and that there may be more frequent latent MS-type disorders that never reach the level of a manifested disease. There seem to be other so-called boosters or activating processes: we have noticed that within the enormous number of American MS patients that were affiicted since 1978, many of them received an inoculation against swine fiu in 1977.

The capacity of EAP to connect or transmit electrical charges by way of the membrane gives this substance a special physiological quality: they are called neurotransmitters. EAP has been valid for some time as a textbook-type neurotransmitter substance, as can be taken from the brilliant lectures of Dr. Pressman in New York. In addition, lately there has been another substance that also deposits near cell membranes (near the inside of the exterior cell membrane) which has been classified as neurotransmitter: aspargin acid or its slats, aspartates.

This is a very condensed and hopefully clear overview over the sum of factors that play a role in the cause of MS. It is obvious that this information significantly deviates from the one that the DMSG (Deutsche Multiple Sclerosis Group) tells the people -- we recommend a comparison.

These discoveries lead to therapeutic concepts and measures that I consider sensible and useful for the treatment of MS.

On the basis of these discoveries, we are pursuing the following program in the treatment of multiple sclerosis:

1. It has to be determined if the patient is located in a geopathogenic zone in his bed or in other places in which he remains for a longer duration, i.e. his desk. A good, qualified and realistic dowser is still the best "instrument" for this experiment, but you can also use another modern technique, i.e. The Mersmann device. Dr. Veronika Carstens who was discredited by the DMSG which she herself sponsors has pointed out the importance of this experiment. If your physician is still frowning upon the suggestion of this experiment, he is most likely lacking the necessary relationship to modern scientism.

2. Diet is of extreme importance. For the aforementioned reasons I recommend avoiding milk products, except for guaranteed naturally fermented French cheese. Glutens are dissimilated by the fermentation process. However, I am not sure if the intake of milk products still plays a role, when the disease is already established. Very few patients out of more than one thousand have indicated to me that their illness has progressed with the intake of milk products.

With the year 1928, Dr. Everssen was able to show in Germany that a strict limitation to raw foods can improve the symptoms of MS. Between 1935 and 1936, Professor Nonne, then president of the German Neurological Society, Hamburg, called together all German neurologists to discuss this unambiguous clinical phenomenon. My father who was a neurologist also attended this discussion. I still remember his report. Nowadays, it is very difficult to follow the Evers diet. It was never established what the effectiveness of the Evers diet is based on.

According to modern findings I would assume that the Kirlian-positivity of the raw foods, in other words, their ability to convert field energy into photon energy, is responsible for this phenomenon. The aforementioned stimulating energy for monitoring substances is provided by the Kirlian-positivity of the raw foods. The function of the adrenaline cortex system can thus be improved. Further observations have revealed that the electrically active beta-carotene possibly plays an important role in the effectiveness of the raw foods. It has been discovered that the intake of beta-carotene in the form of capsules does not seem to have a positive effect on MS

However, we recommend that every MS patient eat lots of raw foods, and in addition olive oil, for another reason still to be discussed.

3. Active and even passive smoking is to be avoided at any rate. The so-called nicotine effect is mainly caused by a malfunction of neurotransmission. For this reason, even very few cigarettes (1 to 3 daily) could worsen the symptoms substantially. We owe the discovery of the nicotine effect onto the electrical transformability of the cell membrane to the French scientist Laborit, who has been a friend of mine for many years. Any exposure to the aforementioned toxic noxae should be avoided. No chlorinated water, no fluoridated water, no fluoride in toothpaste, removal of amalgamated fillings in teeth, a very important task that must be done in stages. Extensive articles about a possible connection between silver-mercury amalgamated fillings and active multiple sclerosis have been published in the United States several times.

After considering these basic measures, an effort can be made to muffle or even cancel the immunological process. Some
decades ago, this has been unconsciously applied by way of an ointment that contains mercury precipitate and was spread in vast areas onto the skin. The clinical results were in fact positive; the toxic side effects, particularly on the kidneys, were extensive.

4. Nowadays, several medications are recommended as immune-inhibiting substances. This includes azathioprine (Imuran, Imurek). There are still patients that use this substance. Its application is dangerous, because azathioprine causes liver damage, tendency to viral infections and possibly cancer when applied for a longer period of time. For this reason, the application of an immune-inhibiting substance that originally was developed against cancer has been popular in the United States. It is cyclophosphamide (Endoxan, Cytoxan). American physicians occasionally use this product on MS patients with toxic dosages. Frequently, we take over such patients with loss of hair and damaged blood-producing bone marrow. The application of Endoxan is not recommended because there is a significantly better alternative: trophosphamide (Ixoten), that is chemically closely related. This substance has the same effectiveness as an immune inhibitor, and is more acceptable in the long run. We have been using Ixoten for about 12 years in the treatment of MS. Usually 50, maximum 100 mg per day, sometimes over a period of 10 to 12 weeks. In some cases, this treatment can be extended to about 100 days (50 mg per day). The indication for the application of Ixoten is a certain immunological examination of the consumption of lymph cells which I cannot explain in detail here. In addition, the personal report of the patient on the basis of his experiences is another factor. Please note: Ixoten treatment is only to be applied for a more or less limited time.

The most important element in the treatment of MS is the attempt to correct the aforementioned chemical and electrical defects in the cell membrane system. The medications selected are the salts of colamine phosphate, calcium EAP, magnesium and potassium EAP (Phosetamin-Mynax in the U.S.A.). The late chemist Dr. Franz Köhler, Alsbach, has synthesized the salts of colamine phosphate in 1961 upon my request. This development was effected with the intention of finding a highly effective and well-acceptable "sealing substance' against the intrusion of viruses and toxic antibodies on a membrane level. In fact, the experiment with the colamine phosphate salts was successful. Mönninghoff published interesting electron-optical experiments in 1972 that reveal almost complete sealing of cell membrane against the intrusion of peroxydase granulas. At this occasion he discovered that the salts of 1-asparagin acid have this sealing effect too. For this reason, we have been using calcium-1-dl-asparaginate (Calciretard-Canax in the U.S.A.) as an anti-immunological sealing substance. Some of our MS patients have been treated for almost 20 years on the basis of Calciretard alone.

Later on it was discovered that colamine phosphate as well as aspartate function as neurotransmitters, are necessary for the connection or the flow of electrical charges to the cell membrane.

Colamine phosphate cannot just be applied in the form of calcium salt -- for certain membrane-physiological reasons, and magnesium and potassium salts have to be taken into consideration. Therefore, our MS patients receive about 8 Mynax tablets daily that also contain magnesium and potassium EAP. Sometimes, calcium EAP has to be given intravenously (available only in Europe); otherwise, the concentration of colamine phosphate for the membranes is not sufficient. Usually, we recommend two to three injections per week.

The disruption of the treatment with colamine phosphate salts leads most likely to the occurrence of a shock in MS patients. We have numerous reports , according to which a premature disruption of intravenous injections (approximately within the first four years) leads to an abrupt deterioration that can be alleviated by the continuation of the injection therapy.

MS patients also receive calcium orotate which has a sealing effect on the level of the membranes within the cells, but not at the exterior cell membranes. The aforementioned inflammatory process at the blood-liquid barrier, possibly damages at the inner structures of oligodendroglia cells, could be positively influenced. The already-mentioned MS variation type Kuwert II requires a stronger consideration of calcium orotate for natural reasons. The tendency to migraine headaches has to disappear completely.

I also recommend to attempt to improve the function of the monitoring systems that seem to be defective in the case of MS. One of these possibilities consists of the intake of Prednison, but not of any other cortisone! Only Prednison enters the so-called thymosterin circulation, provided that additional stimulating energy exists. Vitamin D₂ (not D₃!), also called Ergo-calciferole (available as an oily substance), has a similar function. The application of other synthetic cortisones that do not represent a normal partner of metabolism are only justified in case of an active shock. Triamcinolon (Volon) should be applied in case of acute inflammation of the optic nerve that is caused by the shock.

The bad habit to supply MS patients with ACTH (adrenocorticotropes hormone) is unfortunately wide-spread. ACTH temporarily improves the symptoms, but it also accelerates the deterioration. This is understandable, because ACTH stresses the adrenaline cortex system, which is already very exhausted, on a long-term basis. If ACTH needs to be applied on a short-term basis, then the feeding of the adrenaline cortex system is absolutely necessary: raw foods, vitamin D₂, vitamin C in higher dosages, beta-carotene and especially selenium approximately 50 to 200 mg per day. We have not used ACTH on our MS patients for more than ten years.

Recently, we discovered another very interesting aspect: about 5 years ago, the Smithsonian Institute in Washington reported that sharks practically never have cancer (one tumor in 25,000 animals). The very important substance that is responsible for this phenomenon in the shark is squalene. It is a so-called tripertenoid, a very old precursor substance of steroid that dates back to early evolution. There are other substances which we assume could fulfill monitoring tasks in the human organism. Iridodial is one of them. Squalene also has another characteristic: it is extremely Kirlian-positive; it converts field energy into photon energy. In this manner, the shark gains a large part of his energy from space, and only a small part from food. This also is valid for insects that obtain 90% of their energy from space energy, not from food. Gelèe royale is one of the particularly Kirlian-positive products of insects. Please note: insects are extremely resistant against viruses and cancer, without, however, possessing a protein immune
system.

About 2H years ago, we introduced squalene in the treatment of cancer, with good success. The substance is receptive without doubt, but has to be obtained from Japan in preconditioned form and has to be prepared as a medication in a special way. Squalene does not just appear to be a precursor substance for the required monitoring substances; it also provides the necessary stimulating energy for such substances by way of the Tesla-function. Some facts indicate that the polarization of the cell membrane system is significantly increased by squalene, and its Orgon-function is also activated. Patients that take in one to two teaspoons of squalene per day feel a lot warmer -- subjectively as well as objectively. For the already discussed reasons it seems appropriate to supply MS patients with squalene as well. The results seem to be extremely good according to our observations: the limbs seem to be a lot warmer, the patients don't feel cold any more -- a clear improvement of the symptoms.

Olive oil also contains squalene, up to 2%. Thus the recommendation in the diet of MS patients to use olive oil. But it cannot replace the therapeutic intake of squalene.

The tendency of MS patients to suffer from urinary tract infections has to be taken very seriously. The strong tendency to such infections is caused by the malfunction of the electrostatic defense filter in the urinary tracts. Harnosal (Germany), a sulfonamide, has proven particularly successful on a long-term basis. The effectiveness is not so much based on the bacteria-inhibiting sulfonamide-effect, but on the electrostatic activity that the discharged harnosal develops in the urinary tract. About three tablets per day are sufficient.

In cases of bladder spasms, use Spasmo Harnosal in three week intervals.

The success rates for this treatment vary a lot. The shorter the history of disease, the more favorable the improvement. There are a number of criteria that play a role in reference to the bad or good reaction to the therapy: unfortunately, I cannot discuss them all in detail. But one fact is impressive: the success rate of American patients is better than the rate of German or South African patients. We have developed numerous theories in this respect, but cannot discuss all of them in detail here.

The function of the bladder, of the colonic sphincter and the motoric mobility of the large toes in severely paralyzed patients, usually improve relatively well, sometimes reaching normal conditions. This observation indicates that damages in the lower area of the spinal marrow are more of an electro-functional than of a destructive nature. Even malfunctions in the upper area of the body are improved: dizziness, over-pronouncing of the language, nervous facial twitching, the functioning of hands and arms, particularly bulbar malfunctions that are potentially dangerous (swallowing, breathing, circulation). These vital bulbar functions are supported by colamine phosphate salts on a long-term basis, even in the case of amyotrophic lateral sclerosis.

Unfortunately, the motoric functional disorders of the thigh muscles, a substantial element of walking, are relatively resistant against this therapy; the improvements in this area are limited to a small number of patients. However, if the patients begin this therapy in an early stage, malfunctions in this area can be avoided. We were able to observe that, within the period of 5 years, only 2 out of 100 patients that were still able to walk at beginning of therapy, had to be confined to a wheelchair. Unfortunately, among the more than 1,700 MS patients, there were only 60 that applied this treatment in an early stage of established illness. Among these patients there is a special group that has been treated since 1968. In all cases, the MS condition is not worse than in 1968.

When applying short-term clinical treatment, disorders of the cerebellum (ataxia and dizziness) can be improved. A German MS clinic in Hachen reported this back in 1968. Therefore, the German Ministry of Health which had declared calcium EAP officially as MS medication 2 years earlier, limited the indication to MS disorders related to the cerebellum. In actuality this is not correct; according to long-term observations we have discovered that other MS symptoms can have a better improvement than the ones related to the cerebellum. Please note that another reflection of cerebellum illness, the so-called familial cerebella-atrophy, cannot be influenced by colamine phosphate salts. However, I myself did not apply for a correction of indication declaration, since multiple sclerosis is still listed as an indication on the packages of calcium EAP.

The results that can be achieved with this therapeutic program over the period of more than twenty years are significant and in any case better than any alternatives that have been applied so far. Here are some results from an American group of patients that seem to have reacted more favorably:

• Toledo, Ohio*: continuous improvement in 34 of 35 patients;
• Southeastern United States*: continuous improvement in 20 out of 22 patients;
• Montana*: 4 out of 5 patients improved, the other not deteriorating;
• Wisconsin*, a city near Milwaukee: 10 out of 10 patients improved.

There is a series of therapeutic programs that have become popular within the past ten years. This includes the intake of fatty acids the organism cannot degrade that are sold under the names Efamol and Naudicelle. Even though they are recommended by responsible parties of the DMSG, we were not able to observe any positive effect; however, it caused a hampering of the EAP therapy effect, and this allows certain conclusions. The application of these oils is now prohibited in the United States.

Dr. Jonas E. Salk, La Jolla, California, developer of the Salk inoculation against poliomyelitis, is experimenting with alkaline mucoids. Basically, he is creating a "deviating bait," that is supposed to keep the immune reaction away from the myelin membranes. This may be a textbook-type immunological "absorption procedure;" however, we have occasionally accepted patients from Dr. Salk's experimental group, because the illness did not subside. As a result of the application of these alkaline substances, a very high lymph cell concentration has formed in the blood, which is extremely undesirable. Meanwhile, we have heard that Dr. Salk's program is not conducted any further; it has been buried in all silence.

The inoculation of pork brain beneath the skin as practiced by Dr. Jelesic is similar to the Salk program. Even though this program is not particularly successful, some positive observations have been made by qualified medical personnel; it still possesses
a medical theoretical basis and is no humbug, as the responsible parties of the DMSG are trying to tell the people.

In the Sixties, I have occasionally reported in the international scientific press about the application of colamine phosphate salts in the treatment of MS; however, only in English, with one exception. In 1974, I gave a paper at a medical congress in the Washington Hilton in front of more than 400 physicians. In the spring of 1984, the German rainbow press published a report about this method, and this twenty years after its introduction. The secretary of the DMSG, Munich, wrote to me and explained that he knows of seven interested parties that would like to inspect the therapy and patients in our hospital. Since I cannot have that many visitors due to work-technical reasons, I selected two of them, among them a colleague, Dr. Von Brasch, who wrote to me he had already treated 88 patients with good results. Two clinical neurologists that operate in Hannover could not be invited, because I had patients that did not care to have any kind of contact with or even be treated by these physicians.

Prior to the planned selective clinical visit, particularly with Dr. Von Brasch, the DMSG sent their members a pamphlet about my activities -- nasty and false scribble. It starts with the supposition that the therapy is ineffective, stressful, undeclared, not covered by the federal insurance carriers (all untrue), continues with the ridiculing of the effect of geopathogenic zones and ends with the implication that I give my patients 300 mg selenium per day (that would be a fatal dosage sooner or later). They are warning about this therapy. They consider it an outsider method that is dangerous.

In fact, the responsible "experts" of the DMSG have been the outsiders themselves ever since. The Medical Tribune was also pulled into this affair; the editors were given documents that contained grotesque twisted lies. The newsletter that the "experts" of the Deutsche Multiple-Sklerose-Gesellschaft (DMSG) sent their members contains strong libel and the vocation to cut off support. The mailing of such a paper certainly does not live up to the keeping up of public interest.

In view of the atrocity of this incident, we are preparing a black list about the activities of the DMSG and their responsible parties which is going to be rather interesting due to the volume of written materials that we possess including DMSG-internal memorandums. The publication is going to be effected world-wide. The public and thus the MS patients can form their own judgment and make the necessary consequences, if applicable.

May I also recommend that all patients consult their family physician!

*The work that the late Dr. Hans Nieper started is being continued by Dr. Joachim Ledwoch and his colleagues Dr. Heindorf and Mrs. Dr. Tzolova. They have all had many years of experience with Dr. Nieper's therapy and the Paracelsus Klinik. If anyone has any questions, they should contact Sister Monika Malchert at the Paracelsus Clinic.

The recent passing of Dr. Hans Nieper is a severe catastrophe for many, many MS patients throughout the world. If anyone reading this article is practicing the Nieper EAP therapy, please get in touch with Explore! or Keith Brewer Science Library so that a network of practicing physicians can be established for the continuation of Dr. Nieper's life work.

[Back to Top]